Skip Ribbon Commands
Skip to main content
ORF Home > Construction > ORF Signature Projects > Vaccine Research Center Laboratory Expansion, Building 40A (North Tower)

Vaccine Research Center Laboratory Expansion, Building 40A (North Tower)



Building 40A will be a six story, 158,141 GSF addition to the Building 40 NIAID Vaccine Research Center (VRC).  Building 40A will double the available laboratory space of the VRC, and it will house BSL-2 and specialty laboratories, laboratory support space, administrative support space, and conference/meeting rooms.  The VRC is in the forefront of developing vaccines for infectious disease threats, including coronaviruses (SARS-CoV-2, MERS-CoV, SARS-CoV), influenza, HIV/AIDS, and Ebola.  The VRC is frequently called upon to address biodefense threats and global pandemic emerging infectious disease threats. 


Project Officer: Maya M. Kai Kai
Support: James Cameron, Melinda Alexander, Dhanika Ranasinghe, Chuck Boehmer
Cost: $197M
Completion: September 2024



 
This page was last updated on Sep 15, 2021